Document is current
Any future updates will be listed below
-
Authors
Yu, Shao Feng
Michon, Maya
Lingappa, Anuradha F.
Paulvannan, Kumar
Solas, Dennis
Staats, Kim
Ichida, Justin
Dey, Debendranath
Rosenfeld, Jeffrey
Lingappa, Vishwanath R.
-
Funding
Funding for this research was provided by:
Prosetta Biosciences, Inc
Target ALS (IL-2023-C4-L1)
DOD CDMRP (W81XWH2210721)
- License Information
-
More Information
Article History
Received: 8 November 2024
Accepted: 9 April 2025
First Online: 28 April 2025
Declarations
:
: Whole blood collected in purple-top EDTA tubes from healthy individuals or ALS patients under Loma Linda Medical Center IRB# 5160136.
: VRL is CEO of Prosetta Biosciences. AFL is COO of Prosetta Biosciences.
